IL18 and amyloidosis: For interleukins (IL-6, IL-10, IL-18) with pro- or anti-inflammatory properties, we neither found group-differences across A/T/N stages at baseline nor longitudinally, although a trend towards lower CSF IL-18 levels in isolated amyloidosis was observed which did not withstand correction for multiple comparisons.